Treatment of patients with primary open-angle glaucoma with a fixed combination of brimonidine 0.2%/timolol 0.5%: multicenter, open-label, observational study in Germany*

By Thelen Ulrich   Buchholz Patricia   Kimmich Friedemann  

Current Medical Research and Opinion, Vol. 25, Iss. 4, 2009-04 ,pp. : 1003-1009

Informa Healthcare

Access to resources Recommend Favorite

A comparison of the safety and intraocular pressure lowering of bimatoprost/timolol fixed combination versus latanoprost/timolol fixed combination in patients with open-angle glaucoma

By Martinez Antonio   Sanchez Manuel  

Current Medical Research and Opinion, Vol. 23, Iss. 5, 2007-05 ,pp. : 1025-1032

Informa Healthcare

Access to resources Recommend Favorite

Long-term tolerability and efficacy of the combination of amlodipine/valsartan in hypertensive patients: a 54-week, open-label extension study*

By Philipp Thomas   Glazer Robert D.   Zhao Yanxing   Pospiech Rainer  

Current Medical Research and Opinion, Vol. 25, Iss. 1, 2009-01 ,pp. : 187-193

Informa Healthcare

Access to resources Recommend Favorite

Efficacy and safety of doripenem versus piperacillin/tazobactam in nosocomial pneumonia: a randomized, open-label, multicenter study*

By Réa-Neto Álvaro   Niederman Michael   Margareth Lobo Suzana   Schroeder Eric   Lee Michael   Kaniga Koné   Ketter Nzeera   Prokocimer Philippe   Friedland Ian  

Current Medical Research and Opinion, Vol. 24, Iss. 7, 2008-07 ,pp. : 2113-2126

Informa Healthcare

Access to resources Recommend Favorite

Brinzolamide 1%/timolol 0.5%: safety and efficacy of a new fixed-combination IOP-lowering product for glaucoma

By Januleviciene Ingrida  

Current Medical Research and Opinion, Vol. 26, Iss. 11, 2010-11 ,pp. : 2575-2578

Informa Healthcare

Access to resources Recommend Favorite